{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:55Z","timestamp":1791295675846,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1093\/rheumatology\/kel172","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T08:56:58Z","timestamp":1149065818000},"page":"1047-1048","source":"Crossref","is-referenced-by-count":13,"title":["Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis"],"prefix":"10.1093","volume":"45","author":[{"given":"N. M. R.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Erendzhinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,5,30]]},"reference":[{"key":"key\n\t\t\t\t20171012052248_BIB1","doi-asserted-by":"crossref","unstructured":"Komocsi A, Lamprecht P, Csernok E et al. Peripheral blood and granuloma CD4+CD28- T-cells are a major source of IFN-\u03b3 and TNF-\u03b1 in Wegener's granulomatosis. Am J Pathol2002;160:1717\u201324.","DOI":"10.1016\/S0002-9440(10)61118-2"},{"key":"key\n\t\t\t\t20171012052248_BIB2","doi-asserted-by":"crossref","unstructured":"Roux-Lombard P, Lin HC, Peter JB, Dayer JM. Elevated serum levels of TNF soluble receptors in patients with positive anti-neutrophil cytoplasmic antibodies. Br J Rheumatol1994;33:428\u201331.","DOI":"10.1093\/rheumatology\/33.5.428"},{"key":"key\n\t\t\t\t20171012052248_BIB3","doi-asserted-by":"crossref","unstructured":"Ludviksson B, Sneller M, Chua K et al. Active Wegener's granulomatosis is associated with HLA-DR1 CD41\u2009T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol1998;160:3602\u20139.","DOI":"10.4049\/jimmunol.160.7.3602"},{"key":"key\n\t\t\t\t20171012052248_BIB4","doi-asserted-by":"crossref","unstructured":"Deguchi Y, Shibata N, Kishimoto S. Enhanced expression of the tumour necrosis factor\/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol1990;81:311\u20134.","DOI":"10.1111\/j.1365-2249.1990.tb03336.x"},{"key":"key\n\t\t\t\t20171012052248_BIB5","unstructured":"Nassonov E, Samsonov M, Tilz G et al. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis. J Rheumatol1997;24:666\u201370."},{"key":"key\n\t\t\t\t20171012052248_BIB6","doi-asserted-by":"crossref","unstructured":"Noronha I, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int1993;43:682\u201392.","DOI":"10.1038\/ki.1993.98"},{"key":"key\n\t\t\t\t20171012052248_BIB7","doi-asserted-by":"crossref","unstructured":"Lamprecht P, Voswinkel J, Lilienthal T et al. Effectiveness of TNF-\u03b1 blockade with infliximab in refractory Wegener's Granulomatosis. Rheumatology2002;41:1303\u20137.","DOI":"10.1093\/rheumatology\/41.11.1303"},{"key":"key\n\t\t\t\t20171012052248_BIB8","doi-asserted-by":"crossref","unstructured":"Bartolucci P, Ramanoelina J, Cohen P et al. Efficacy of the anti-TNF-\u03b1 antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology2002;41:1126\u201332.","DOI":"10.1093\/rheumatology\/41.10.1126"},{"key":"key\n\t\t\t\t20171012052248_BIB9","doi-asserted-by":"crossref","unstructured":"Booth AD, Jefferson HJ, Ayliffe W, Andrews PA, Jayne DR. Safety and efficacy of TNF-alpha blockade in relapsing vasculitis. Annal Rheum Dis2002;61:559","DOI":"10.1136\/ard.61.6.559"},{"key":"key\n\t\t\t\t20171012052248_BIB10","doi-asserted-by":"crossref","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum1990;33:1101\u20137.","DOI":"10.1002\/art.1780330807"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/45\/8\/1047\/9448457\/kel172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T15:33:09Z","timestamp":1683473589000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/rheumatology\/article\/45\/8\/1047\/2899435\/Infliximab-as-rescue-therapy-in-three-cases-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,30]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,5,30]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kel172","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,8]]},"published":{"date-parts":[[2006,5,30]]}}}